Meeting
2016 Cancer Survivorship Symposium
Psychotropic and stimulant medication (PSM) use among testicular cancer survivors (TCS): A multi-institutional clinical study of 680 patients given cisplatin-based chemotherapy (CHEM) (NCI 1R01 CA157823-02).
Authors
Somer Case-Eads
Indiana University, Indianapolis, IN
Somer Case-Eads , Lois B. Travis , Chunkit Fung , Howard D. Sesso , Darren R. Feldman , David J. Vaughn , Robert James Hamilton , Eileen Johnson , Derick R Peterson , Sophie D. Fossa , Lawrence H. Einhorn , Clair Beard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Care Coordination and Financial Implications,Communication,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Recurrence and Secondary Malignancies
Sub Track
Quality-of-Life Issues
Citation
J Clin Oncol 34, 2016 (suppl 3S; abstr 242)
DOI
10.1200/jco.2016.34.3_suppl.242
Abstract #
242
Poster Bd #
P1
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Impact of adverse health outcomes (AHOs) on self-reported physical and mental health in U.S. testicular cancer survivors (TCS).
First Author: Paul C. Dinh Jr.
Poster
2021 ASCO Annual Meeting
Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy.
First Author: Shirin Ardeshirrouhanifard
Poster
2021 Genitourinary Cancers Symposium
Paternity, relationship, sexual activity and fertility in testicular cancer (TC) survivors (TCS): Results from a single institution observational prospective study.
First Author: Davide Bimbatti
Poster
2016 Cancer Survivorship Symposium
Cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study.
First Author: Sarah L Kerns